Dot1L-IN-7

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Dot1L-IN-7 

Dot1L-IN-7 (compound 25) 是一种有效的、选择性的端粒沉默 1 样蛋白 (DOT1L) 抑制剂，IC50 为 1.0 μM。Dot1L-IN-7 选择性地杀死MLL-AF9，而对 E2A-HLF 细胞的生长没有任何影响。

Dot1L-IN-7

Dot1L-IN-7 Chemical Structure

CAS No. : 2580940-76-5

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Dot1L-IN-7 (compound 25) is a potent and selective disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor with an IC50 of 1.0 μM. Dot1L-IN-7 selectively killed Mixed Lineage Leukemia (MLL)-AF9 without showing any effect on the growth of E2A-HLF cells[1].

IC50 & Target[1]

DOT1L

1 μM (IC50)

分子量

461.52

Formula

C23H27N9O2
CAS 号

2580940-76-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Garrett S Gibbons, et al. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library. Eur J Med Chem. 2020 Mar 1;189:112023.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务